{
    "organizations": [],
    "uuid": "82344e6b35737e5369d6da39deb72c428a83a1db",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/22/the-associated-press-biomarin-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "BioMarin reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN RAFAEL, Calif. (AP) _ BioMarin Pharmaceutical Inc. (BMRN) on Thursday reported a loss of $51.4 million in its fourth quarter.\nThe San Rafael, California-based company said it had a loss of 30 cents per share.\nThe results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.\nThe rare disease biopharmaceutical posted revenue of $358.3 million in the period, which topped Street forecasts. Ten analysts surveyed by Zacks expected $346.2 million.\nFor the year, the company reported that its loss narrowed to $117 million, or 67 cents per share. Revenue was reported as $1.31 billion.\nBioMarin expects full-year revenue in the range of $1.47 billion to $1.53 billion.\nBioMarin shares have dropped roughly 6 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $84, a drop of slightly more than 6 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on BMRN at https://www.zacks.com/ap/BMRN",
    "published": "2018-02-22T23:31:00.000+02:00",
    "crawled": "2018-02-23T01:05:15.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "rafael",
        "ap",
        "biomarin",
        "pharmaceutical",
        "bmrn",
        "thursday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "san",
        "rafael",
        "company",
        "said",
        "loss",
        "cent",
        "per",
        "share",
        "result",
        "missed",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "rare",
        "disease",
        "biopharmaceutical",
        "posted",
        "revenue",
        "million",
        "period",
        "topped",
        "street",
        "forecast",
        "ten",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "cent",
        "per",
        "share",
        "revenue",
        "reported",
        "billion",
        "biomarin",
        "expects",
        "revenue",
        "range",
        "billion",
        "billion",
        "biomarin",
        "share",
        "dropped",
        "roughly",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "thursday",
        "share",
        "hit",
        "drop",
        "slightly",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "bmrn",
        "http"
    ]
}